Abstract
Introduction
Mounting evidence indicates the possible use of Mesenchymal Stem Cells (MSCs) as therapeutical agents # These authors contributed equally to the work.
for different CNS-related problems. Most studies have focused on MSCs' impact on phenomena such as neural cell proliferation and differentiation. For instance, Munoz et al. (2005) revealed that the implantation of human MSCs in the mousee dentate gyrus (DG) stimulated proliferation, migration and differentiation of the endogenous neural stem cells populations. Other authors have also revealed that the transplantation of MSCs into different animal injury/disease models, such as stroke (Li et al., 2005; Li and Chopp, 2009) , spinal cord injury (SCI) (Deng et al., 2006; Urdziková et al., 2006) or Parkinson's Disease (PD) (Chao et al., 2009; Park et al., 2008; Shintani et al., 2007) led to a significant reduction in the volume of damaged tissues, increased cognitive capabilities upon injury or a significant improvement in motor skills. While these effects can be ascribed to the proliferation/differentiation of local neural stem cell (NSC) populations, there is also a strong possibility that they are related to the trophic influence on the survival and protection of mature resident glial and neuronal cell populations. Reports such as those presented by Bai et al. (2007) , Crigler et al. (2006) and Wislet-Gendebien et al. (2004) clearly indicate that the secretome of MSCs possesses regulatory factors able to stimulate neuronal, oligodendrogenic and astrocytic survival/protection and differentiation. Nevertheless, although there has been an increasing body of literature dealing with effects of the secretome of MSCs in the CNS, there are still some missing gaps within the field. For instance, few reports deal with the effects of the secretome of MSCs on mature cultures of postnatal neurons and glial cells, as most in vitro studies have been performed with NSCs. Moreover, as the secretome of MSCs might change with time, it is also relevant to characterize the temporal profile of conditioned media (CM) collection in terms of cell viability, survival and cell densities, as subtle changes in the CM might stimulate some cell populations while inhibiting others. Therefore, the objectives of the present study were to evaluate the effects of MSCs conditioned media and the temporal profile of its collection on the viability and cell densities of post-natal cultures of hippocampal neurons and glial cells. The results revealed that the time point of MSCs CM collection distinctly affects neurons, astrocytes, oligodendrocytes and microglial cells.
Materials and methods
Bone marrow MSCs (BM-MSCs) were acquired from Lonza (Basel, Switzerland). Upon arrival they were thawed and expanded according to the company guidelines. Hippocampal neuron cultures were prepared from P4 Wistar rats (Lu et al., 2005) . Briefly, and upon dissection, the hippocampi were submitted to trypsin-based enzymatic digestion followed by mechanical dissociation. Isolated cells were then plated on coverslips previously coated with poly-D-lysine (Sigma, USA) at a density of 40 000 cells/cm 2 . Cortical glial cells were isolated from P4 newborn Wistar rats (Salgado et al., 2009) . Upon dissection, the cortices were enzymatically digested (30 mg/ml DNase, 0.25% trypsin; both from Sigma), followed by strong mechanical dissociation. Glial cells were then obtained by centrifuging the resulting cell suspension at 800 rpm for 2 min and were plated out on coverslips previously coated with poly-D-lysine at a density of 40 000 cells/cm 2 . CM were collected from P5 MSCs. For this purpose, the cells were plated out at a density of 4000 cells/cm 2 and allowed to grow for 3 days. Following this, the culture medium was renewed and CM collected 24, 48, 72 and 96 h thereafter (cell culture medium was not renewed or added during this time period). Upon collection, the CMs were frozen and later thawed on the day of the experiments. For CM collection, standard MSCs culture medium was used for experiments with glial cells, while for experiments with hippocampal neurons, Neurobasal-A medium (Gibco, USA) supplemented with kanamycin (0.1 mg/ml; Gibco) was the chosen medium.
Experiments with glial cells and hippocampal neurons were performed as follows.
Hippocampal neurons. Upon isolation, hippocampal neurons were plated out at the densities referred to above and incubated from T 0 with the previously collected CM (n = 3/CM time point) for 7 days (with half of the volume of CM being renewed at day 4 of culture), after which cell densities, viability and proliferation were assessed (see below). Besides kanamycin and glutamax, no further supplements were added to the MSCs CM. Control cultures were kept in neurobasal medium supplemented with kanamycin and glutamax.
Glial cells. Upon isolation, glial cells were allowed to grow for 5 days. On day 5 the culture medium was switched to CM (n = 3/CM time point); after incubation for further 9 days, cell densities and viability were assessed (see below). Control cultures were kept in α-MEM supplemented with 1% antibiotics/antimycotics (Sigma). The different time periods of CM incubation for neurons and glial cells were mainly related to their maturation stage. For hippocampal neurons, the maturation stage is 7 days, while for cortical glial cells it is 14 days (Lu et al., 2005; Salgado et al., 2009) .
Cell viability was assessed by the MTS test. Cell culture coverslips (n = 3) were placed in culture medium containing (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2(4-sulfophenyl)-2H tetrazolium) (MTS) in a 5 : 1 ratio and incubated in a humidified atmosphere at 37
• C and 5% CO 2 . After 3 h of incubation, 100 µl solution from each sample were transferred to 96-well plates and the optical density was determined at 490 nm (n = 3/CM time point ± SD).
Immunocytochemistry was performed according to our previously described procedures (Salgado et al., 2010) . The following primary and secondary antibodies were used: mouse anti-rat microtubule-associated protein 2 (MAP-2; Sigma, USA) to detect mature hippocampal neurons; rabbit anti-rat glial fibrillary acid protein (GFAP; Dako, Denmark) for astrocytes; mouse anti-CD11b (BD Biosciences, Pharmigen, USA) for microglial cells; mouse anti-O4 (R&D Systems, USA) for oligodendrocytes; Alexa Fluor 594 goat anti-mouse immunoglobulin G (IgG) and Alexa Fluor 488 rabbit anti-rat IgG. Nuclei were counterstained with DAPI (Molecular Probes). Primary antibody was omitted to produce negative controls. Samples were observed under a Olympus BX-61 fluorescence microscope (Olympus, Germany).
Cell counts were performed by using Cell-P software (Olympus, Germany). For this purpose, three cover slips per condition and three representative fields were chosen and analysed. In order to normalize the data between the different sets of cell cultures, the results are presented in percentages of cells. This was calculated by counting the cells positive for the above-referred markers and dividing this value by the total number of cells/field (DAPI-positive cells). Statistical evaluation was performed using oneway ANOVA to assess the statistical differences between different groups. Statistical significance was defined as p < 0.05 for a 95% confidence interval.
Results and discussion
In the present report we aimed to determine how CM from MSCs collected at different time points affected the metabolic viability and cell densities in primary cultures of post-natal (P4) hippocampal neurons and cortical glial cells. As can be observed in Figure 1A , the incubation of hippocampal neuronal cultures with MSCs CM leads to an increase of the metabolic viability; values from all time points were above control cultures (CM 24 h and CM 72 h, p < 0.05). Analysis of differentiated neurons (by observing MAP-2 immunostained coverslips) revealed that CM 24 h triggers the most striking effect on neuronal densities (Figure 1B, C) : with this CM, approximately 20% (p < 0.05) of MAP-2-positive cells could be observed, which corresponds to four times more than those presented in the control condition (p < 0.05). It should be noted that the low values obtained by the control were expected, as cultures were kept without the B27 supplement. In primary cultures of postnatal cortical glial cells, the results for the metabolic viability upon incubation with MSCs CM were variable. As can be observed in Figure 2A , the two initial CM time points had lower levels of metabolic viability when compared to control cultures (p < 0.05). This effect was then inverted with CM 96 h, disclosing a small but statistically significant increase in glial cell viability (p < 0.05) when compared to the control. Immunostaining for GFAP (astrocytes; Figure 2B , E, H), CD11b (microglial cells; Figure 2C , F, I) and O4 (oligodendrocytes; Figure 2D , G, J) revealed distinct effects at the subpopulation level. The most relevant effects for astrocytes were achieved with MSCs CM 48 h and CM 72 h (p < 0.05). On the other hand, we observed reduced microglial cells densities whenever cultures were incubated with MSCs CM 24 h. Finally, oligodendrocytes densities seem to be negatively affected by the initial MSCs CM (24 h and 48 h). While the results obtained with microglial cells were expected, as it is known the immunomodulatory phenotype of MSCs on inflammatory cells, including microglial cells (Kim et al., 2009; Ohtaki et al., 2008; Rossignol et al., 2009; Zhou et al., 2009) , the results obtained for astrocytes and oligodendrocytes were quite surprising. Previous oligodendrogenic differentiation was only achieved with longer periods of MSC conditioning (Bai et al., 2007) . Therefore, these results show that the temporal profile of the CM secretome determines its effects on mature and differentiated cells.
